-
Feed Type
-
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=1c5cb00a-48bd-4114-9719-ffe00f71fdc5&Preview=1 -
Date
12/27/2010 -
Company Name
Adynxx -
Mailing Address
665 3rd St. San Francisco, CA 94107 -
Company Description
The company is dedicated to developing the next breakthrough therapeutic treatments for chronic pain. -
Website
http://www.adynxx.com -
Transaction Type
Venture Equity -
Transaction Amount
$4,803,858 -
Transaction Round
Series A -
Proceeds Purposes
Proceeds purposes were not disclosed. SEC regulatory filing. -
M&A Terms
-
Venture Investor
Undisclosed













